The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma.
 
Masato Ozaka
Honoraria - Bayer; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Takashi Sasaki
No Relationships to Disclose
 
Ikuhiro Yamada
No Relationships to Disclose
 
Ryo Kanata
No Relationships to Disclose
 
Dai Akiyama
No Relationships to Disclose
 
Tomoko Katagiri
No Relationships to Disclose
 
Koichi Takano
No Relationships to Disclose
 
Masato Matsuyama
No Relationships to Disclose
 
Naoki Sasahira
Honoraria - Cook Medical; Toshiba
Consulting or Advisory Role - Boston Scientific
Research Funding - Baxalta; Eisai; Kyowa Hakko Kirin; Taiho Pharmaceutical; Zeria Pharmaceutical